InnovAge (INNV) KeyBanc Annual Health Care Forum 2025 summary
Event summary combining transcript, slides, and related documents.
KeyBanc Annual Health Care Forum 2025 summary
26 Dec, 2025PACE market overview and value proposition
PACE provides comprehensive medical and social services to frail, dual-eligible seniors as an alternative to institutional care, enabling them to remain at home or in assisted living.
The model integrates care delivery and payment, taking full financial risk and offering budget certainty to states through capitation.
PACE programs save states money by reducing institutionalization, improving care coordination, and lowering healthcare cost inflation.
The program supports both participants and their families, enhancing quality of life and independence.
PACE is gaining attention from investors and regulators due to its performance during the pandemic and potential for growth.
Company positioning and competitive advantages
Operates the largest PACE provider network, serving 7,500 participants across 20 centers in six states.
Scale enables investment in advanced clinical, operational, and financial technology, such as Epic and Oracle systems.
Developed a repeatable blueprint for center growth, acquisitions, and new market entries.
Attracts top healthcare talent, competing with large managed care and provider organizations.
Strong capital structure supports strategic growth initiatives.
Operational improvements and compliance
Addressed significant compliance gaps and audit deficiencies through automation, process redesign, and talent investment.
Implemented Epic to automate record-keeping and reduce human error.
Strengthened relationships with state officials and CMS to rebuild confidence.
Shifted focus from remediation to operational excellence and platform development for future growth.
Latest events from InnovAge
- Q2 revenue and margins surged, raising full-year guidance despite ongoing cost and regulatory risks.INNV
Q2 20263 Feb 2026 - Care coordination, trust, and tailored technology are key to advancing aging-in-place models.INNV
7th Annual Healthcare Symposium3 Feb 2026 - Revenue up 11% with margin gains and positive Adjusted EBITDA; 2025 outlook remains strong.INNV
Q4 202421 Jan 2026 - Revenue up 12.4%, net loss halved, and Adjusted EBITDA margin improved to 3.2%.INNV
Q1 202516 Jan 2026 - Integrated care platform drives growth, margin expansion, and superior outcomes for complex seniors.INNV
44th Annual J.P. Morgan Healthcare Conference12 Jan 2026 - Revenue up 10.6% to $209M; FY2025 guidance reaffirmed amid margin and regulatory pressures.INNV
Q2 20259 Jan 2026 - Virtual meeting to elect directors, ratify auditor, and approve officer exculpation amendment.INNV
Proxy Filing1 Dec 2025 - Director elections and auditor ratification headline a meeting focused on governance and oversight.INNV
Proxy Filing1 Dec 2025 - Annual meeting to elect directors, ratify auditor, and approve officer exculpation amendment.INNV
Proxy Filing1 Dec 2025